je.st
news
Tag: focus
Focus - Anheuser-Busch InBev's Q1 Performance by Region
2014-05-07 13:30:00| Daily beverage news and comment - from just-drinks.com
Earlier today (7 May), Anheuser-Busch InBev reported a rise in first-quarter group sales, but net profits were dragged down by higher finance costs. Here just-drinks takes a look at the brewer's performance in its global markets:
Tags: region
performance
focus
anheuserbusch
Disease Continues to be Focus of Global Pork Markets, Reports Rabobank
2014-05-07 02:00:00| ThePigSite - Industry News
GLOBAL - Pork shortages will be a key concern in many countries in the coming months.
Tags: global
reports
focus
disease
HUNTIN' DAYLIGHT -- HIGHER PRICES DEMAND TIGHTER MANAGEMENT FOCUS
2014-05-06 23:35:57| Cattle Today
“Cattle and beef dynamics will depend on precipitation patterns during the remainder of 2014,” say analysts in the April Livestock, Dairy and Poultry Outlook.
Tags: management
prices
higher
focus
U.S. stock futures fall; Merck in focus
2014-05-06 19:41:22| Grocery - Topix.net
U.S. stock futures reversed gains Tuesday as investors digested a trade deficit that generally met expectations as well as earnings and deal news in the pharmaceutical sector.
Tags: stock
fall
focus
futures
Merck Highlights Progress on Its Strategic Initiative to Sharpen Commercial and R&D Focus; Drive Growth and Productivity
2014-05-06 14:59:00| Merck.com - Corporate News
Dateline City: BOSTON Company Provides Updates on Near-Term Opportunities and Immuno-Oncology Strategy Announced Sale of Consumer Care Business to Bayer AG for $14.2 Billion; Enters into Worldwide Collaboration with Bayer to Market and Develop Novel Therapies for Cardiovascular Disease MK-3475 BLA Accepted for Priority Review by FDA; Company Announced Plans to File in EU in 2014 Provided Updates on Clinical Development Programs for Oncology, Hepatitis C and HIV Confirmed Plans to File Odanacatib for the Treatment of Osteoporosis in Second Half of 2014 BOSTON--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today is hosting an Investor Briefing at the companys research facility in Boston. The briefing is also available via webcast at www.merck.com starting at 9:00 a.m. EDT. Language: English Contact: MerckMedia:Steve Cragle, 908-423-3461Ian McConnell 908-423-3046Investor:Joe Romanelli, 908-423-5185Carol Ferguson, 908-423-4465 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: drive
commercial
focus
growth
Sites : [349] [350] [351] [352] [353] [354] [355] [356] [357] [358] [359] [360] [361] [362] [363] [364] [365] [366] [367] [368] next »